Komplikationen der Behandlung von Neoplasien des konjunktivalen Plattenepithels mit Interferon-α-2b bei rheumatoider ArthritisComplications in the treatment of ocular surface squamous neoplasia with interferon α‑2b in rheumatoid arthritis

被引：0
|
作者：
E. Torres Suárez
R. Pinheiro
N. Schrage
机构：
[1] Kliniken der Stadt Köln,Augenklinik, Krankenhaus Merheim
来源：
Der Ophthalmologe | 2017年 / 114卷 / 2期
关键词：
Neoplasie der plattenepithelialen okulären Oberfläche; IFN-α-2b; Komplikationen; Immunsuppression; Rheumatoide Arthritis; Ocular surface squamous neoplasia; IFN α‑2b; Complications; Immune suppression; Rheumatoid arthritis;
D O I：
10.1007/s00347-016-0292-y
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：155 / 158
页数：3
相关论文
共 40 条
  • [31] Study of efficacy and safety of reconstituted, recombinant human interferon alpha 2b eyedrops without refrigeration as a therapy for immunoreduction and/or treatment of ocular surface squamous neoplasia
    Kabra, Namrata S.
    Patil, Vaibhav S.
    Dhanuka, Dolly G.
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2021, 69 (12) : 3776 - 3777
  • [32] Immunochemotherapie des metastasierenden Uveamelanoms mit Interferon-α2b, Interleukin-2 und Fotemustin Kasuistiken und LiteraturübersichtKasuistiken und Literaturübersicht
    Patrick Terheyden
    Eckhart Kämpgen
    Thomas M. Rünger
    Eva-Bettina Bröcker
    Jürgen C. Becker
    Der Hautarzt, 1998, 49 : 770 - 773
  • [33] Risk Factors for Ocular Surface Squamous Neoplasia Recurrence after Treatment With Topical Mitomycin C and Interferon Alpha-2b
    Besley, Jenna
    Pappalardo, Juanita
    Lee, Graham A.
    Hirst, Lawrence W.
    Vincent, Stephen J.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2014, 157 (02) : 287 - 293
  • [34] Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous Neoplasia
    Venkateswaran, Nandini
    Mercado, Carolina
    Galor, Anat
    Karp, Carol L.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2019, 199 : 216 - 222
  • [35] Changes in in vivo confocal microscopic findings of ocular surface squamous neoplasia during treatment with topical interferon alfa-2b
    Zarei-Ghanavati, Mehran
    Mousavi, Ebrahim
    Nabavi, Amin
    Latifi, Golshan
    Mehrjardi, Hadi Z.
    Mohebbi, Masoomeh
    Ghassemi, Hamed
    Mirzaie, Farrin
    Zare, Mohammad Ali
    OCULAR SURFACE, 2018, 16 (02): : 235 - 241
  • [36] Efficacy, safety and cost-effectiveness of 5-fluorouracil versus interferon α-2b as adjuvant therapy after surgery in ocular surface squamous neoplasia in a southern European tertiary hospital
    Llorens, Jose Javier San Roman
    Fernandez-Gurria, Marta
    Artieda, June Artaechevarria
    Alba, Nicolas Alejandre
    Sandoval, Blanca Garcia
    Morote, Ignacio Jimenez-Alfaro
    INTERNATIONAL OPHTHALMOLOGY, 2024, 44 (01)
  • [37] Surgery Versus Interferon Alpha-2b Treatment Strategies for Ocular Surface Squamous Neoplasia: A Literature-Based Decision Analysis
    Siedlecki, Andrew N.
    Tapp, Stephanie
    Tosteson, Anna N. A.
    Larson, Robin J.
    Karp, Carol L.
    Lietman, Thomas
    Zegans, Michael E.
    CORNEA, 2016, 35 (05) : 613 - 618
  • [38] Interferon alpha-2b versus 5-fluorouracil as primary treatment modalities for ocular surface squamous neoplasia: a study of 116 eyes
    Bakal, Komal
    Gupta, Adit
    Kaliki, Swathi
    INTERNATIONAL OPHTHALMOLOGY, 2025, 45 (01)
  • [39] Primary treatment of ocular surface squamous neoplasia with topical interferon alpha-2b: Comparative analysis of outcomes based on original tumor configuration
    Shields, Carol L.
    Constantinescu, Alexandru B.
    Paulose, Sefy A.
    Yaghy, Antonio
    Dalvin, Lauren A.
    Shields, Jerry A.
    Lally, Sara E.
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2021, 69 (03) : 563 - 567
  • [40] Kombinierte Zytokintherapie vs. Misteltherapie bei metastasiertem NierenzellkarzinomKlinischer Vergleich des Therapieerfolgs einer kombinierten Gabe von Interferon alfa-2b, Interleukin-2 und 5-Fluorouracil gegenüber einer Behandlung mit MistellektinCombined cytokine therapy vs mistletoe treatment in metastatic renal cell cancerClinical comparison of therapy success with combined administration of interferon-α2b, interleukin-2, and 5-fluorouracil compared to treatment with mistletoe lectin
    O. A. Brinkmann
    L. Hertle
    Der Onkologe, 2004, 10 (9): : 978 - 985
1234